[1]
“TIRZEPATIDE VERSUS SEMAGLUTIDE: A COMPREHENSIVE REVIEW OF COMPARATIVE EFFICACY, SAFETY, AND METABOLIC OUTCOMES IN TYPE 2 DIABETES AND OBESITY”, IJITSS, vol. 5, no. 4(48), Dec. 2025, doi: 10.31435/ijitss.4(48).2025.4276.